Concomitant with inhibiting cathepsin B and increasing p62 levels, bortezomib also stimulated ERK phosphorylation in ovarian cancer cells (Figure 5d), endometrial cancer Ishikawa cells, and hepatocellular carcinoma HepG2 cells (Supplementary Figure 5). The gene discussed is SQSTM1; the disease is ovarian cancer.